# TADALAFIL
> **ANDA210716** · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL RX · Approved 2020-12-29
## Drug
- **FDA Application Number:** ANDA210716
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TADALAFIL
- **Generic name:** Tadalafil
- **Active ingredients:** TADALAFIL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** CHARTWELL RX
- **First approval:** 2020-12-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210716)
---
*AI Analytics · CC0 1.0*